Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research report issued on Friday, Marketbeat Ratings reports.
Some results have been hidden because they may be inaccessible to you